Best of ASCO - 2014 Annual Meeting

 

Welcome

Brain Metastases

Central Nervous System Tumors

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
Assessment of clinical, radiological and radiomic predictive factors of bevacizumab efficacy in brain metastases radionecrosis treatment.

Aurelien Gobert

e14003

Assessment of efficacy and safety of bevacizumab in the treatment of brain metastases radionecrosis: A retrospective cohort analysis.

Aurelien Gobert

e14014

Brain metastases treated with immune checkpoint inhibitors: A single center experience.

Vidhya Karivedu

e14012

Brain metastasis due to triple-negative breast cancer in the Peruvian population.

Renato Gustavo Luque Benavides

e14013

Discovery of a predictive protein biomarker for leptomeningeal disease after craniotomy and radiation.

Michael Henry Soike

2068

Drug quantification in metastatic brain tumors in patients receiving bendamustine as a radiosensitizer for stereotactic radiotherapy.

Anees Dauki

e14017

Durability of brain metastasis response and overall survival in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab.

Sarah B. Goldberg

2009

Efficacy and safety of endostar combined with whole brain radiotherapy in patients with NSCLC brain metastases.

Xiaorong Dong

e14002

Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614.

Jeffrey Scott Wefel

2065

Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases.

Andrew Bacotti

2063

Incidence of treatment effect and characteristic MRI findings in immunotherapy-treated melanoma patients with brain metastases receiving stereotactic radiosurgery.

Justin Lin Sovich

2066

Management of breast cancer with leptomeningeal disease: Is there a role for high dose intravenous methotrexate? The Medical College of Wisconsin’s single institution experience.

Jonathan Thomas Kapke

e14018

MicroRNA-330-3p as a putative promoter of brain metastasis in non-small cell lung cancer.

Chunhua Wei

e14007

MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases.

Ankush Bhatia

2069

Mutational complexity increases in lung adenocarcinoma (LADC) with the development of brain metastasis (BM).

Matthew K Stein

2067

National Cancer Database analysis on patterns of care for brain metastases.

Catherine R. Garcia

e14001

Neurological death in patients with EGFR-mutant non-small cell lung cancer.

Matthew Ramotar

2062

Optimal treatment sequence for untreated EGFR-mutant NSCLC with brain metastases.

Eriko Miyawaki

e14021

Outcomes of lung cancer patients with leptomeningeal metastases in the targeted therapy era.

Kathryn Sara Nevel

2064

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer with central nervous system metastases.

Aki Morikawa

e14016

Phase II study of pembrolizumab in leptomeningeal carcinomatosis.

Priscilla Kaliopi Brastianos

2007

Prostate cancer brain metastasis in a contemporary cohort.

Paul Brittain

e14011

Radiosurgery and immune checkpoint inhibition in the treatment of brain metastases: A meta-analysis of patient-level data.

Eric J Lehrer

e14009

Real-world study to quantify the symptom and disease burden of central nervous system (CNS) metastases (mets) in non-small-cell-lung cancer (NSCLC).

Gracy Crane

e14019

Risk of CNS adverse events (CNS-AEs) for patients with non-small cell lung cancer (NSCLC) and melanoma brain metastases (BM) treated with CNS radiation (CNS-RT) and immune checkpoint inhibitors (CPIs).

Michael Edward Devitt

2010

Risk-adjusted survival for melanoma brain metastases in the era of checkpoint blockade immunotherapies: Results from a national cohort.

Bryan Iorgulescu

2011

Role of cerebrospinal fluid (CSF) in the pathogenesis and treatment of patients with brain metastases.

Ayesha Ali

e14006

The role of PIDD gene in the radiation-induced brain injury.

Fan Tong

e14008

The spatial distribution of brain metastasis.

Emory McTyre

e14000

Timing, presentation, and patterns of failure of leptomeningeal disease after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis.

Roshan Sudhir Prabhu

2070